Patents by Inventor Douglas Hanniford

Douglas Hanniford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160298198
    Abstract: The invention relates to miRNA-based methods for prognosis of melanoma brain metastasis and related methods and kits. In one embodiment, the invention provides a method for predicting the likelihood of developing melanoma brain metastasis (B-Met) in a subject diagnosed with primary melanoma, said method comprising determining the levels of miR-150-5p, miR-15b-5p, miR-16-5p, and miR-374b-3p in a primary melanoma sample collected from the subject.
    Type: Application
    Filed: November 13, 2014
    Publication date: October 13, 2016
    Applicant: New York University
    Inventors: Eva Hernando-Monge, Douglas Hanniford, Hua Zhong, Iman Osman
  • Publication number: 20150126621
    Abstract: Described herein are miRNA-based methods for prognosis of recurrence of melanoma and related methods and kits. The present invention addresses these and other needs by providing a method for predicting the likelihood of recurrence of melanoma (including distal metastasis and locoregional recurrence) in a subject diagnosed with melanoma. In a separate aspect, the invention provides a method for treatment of a melanoma recurrence (including distal metastasis and locoregional recurrence) in a subject in need thereof.
    Type: Application
    Filed: May 15, 2013
    Publication date: May 7, 2015
    Applicant: New York University
    Inventors: Douglas Hanniford, Eva Hernando-Monge, Iman Osman, Shulian Shang, Yongzhao Shao
  • Patent number: 8748098
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: June 10, 2014
    Assignee: New York University
    Inventors: Eva Hernando, Miguel Segura, Douglas Hanniford, Silvia Menendez
  • Publication number: 20120322743
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: August 8, 2012
    Publication date: December 20, 2012
    Applicant: NEW YORK UNIVERSITY
    Inventors: Eva Hernando, Miguel F. Segura, Douglas Hanniford, Silvia Menendez
  • Patent number: 8252760
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: August 28, 2012
    Assignee: New York University
    Inventors: Eva Hernando, Miguel F. Segura, Douglas Hanniford, Silvia Menendez
  • Publication number: 20090238896
    Abstract: Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.
    Type: Application
    Filed: March 24, 2009
    Publication date: September 24, 2009
    Applicant: NEW YORK UNVERSITY
    Inventors: EVA HERNANDO, MIGUEL F. SEGURA, DOUGLAS HANNIFORD, SILVIA MENENDEZ